The Role of Cytochrome P450 AbyV in the Final Stages of Abyssomicin C Biosynthesis.


Journal

Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543

Informations de publication

Date de publication:
16 01 2023
Historique:
received: 05 09 2022
pubmed: 1 11 2022
medline: 12 1 2023
entrez: 31 10 2022
Statut: ppublish

Résumé

Abyssomicin C and its atropisomer are potent inhibitors of bacterial folate metabolism. They possess complex polycyclic structures, and their biosynthesis has been shown to involve several unusual enzymatic transformations. Using a combination of synthesis and in vitro assays we reveal that AbyV, a cytochrome P450 enzyme from the aby gene cluster, catalyses a key late-stage epoxidation required for the installation of the characteristic ether-bridged core of abyssomicin C. The X-ray crystal structure of AbyV has been determined, which in combination with molecular dynamics simulations provides a structural framework for our functional data. This work demonstrates the power of combining selective carbon-13 labelling with NMR spectroscopy as a sensitive tool to interrogate enzyme-catalysed reactions in vitro with no need for purification.

Identifiants

pubmed: 36314667
doi: 10.1002/anie.202213053
pmc: PMC10107801
doi:

Substances chimiques

abyssomicin C 0
Cytochrome P-450 Enzyme System 9035-51-2
Bridged Bicyclo Compounds, Heterocyclic 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202213053

Subventions

Organisme : Engineering and Physical Sciences Research Council
ID : EP/G036764/1
Organisme : Engineering and Physical Sciences Research Council
ID : EP/L016494/1
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L01386X/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/T001968/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M012107/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/T008741/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M026280/1
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Références

J Phys Chem B. 2010 Jan 21;114(2):1156-62
pubmed: 20014756
Appl Microbiol Biotechnol. 2014;98(14):6185-203
pubmed: 24848420
Angew Chem Int Ed Engl. 2005 Oct 14;44(40):6533-7
pubmed: 16163781
Angew Chem Int Ed Engl. 2007;46(43):8284-6
pubmed: 17886307
Angew Chem Int Ed Engl. 2008;47(46):8872-5
pubmed: 18855960
Nucleic Acids Res. 2018 Jul 2;46(W1):W363-W367
pubmed: 29860391
J Am Chem Soc. 2007 Jan 17;129(2):429-40
pubmed: 17212423
Nucleic Acids Res. 2007;35(6):e45
pubmed: 17317681
Nucleic Acids Res. 2022 Jul 5;50(W1):W210-W215
pubmed: 35610055
Tuberculosis (Edinb). 2010 Sep;90(5):298-300
pubmed: 20739223
Chem Biol. 2008 Sep 22;15(9):950-9
pubmed: 18804032
Front Microbiol. 2018 Aug 22;9:2007
pubmed: 30186281
J Antibiot (Tokyo). 2004 Apr;57(4):271-9
pubmed: 15217192
Angew Chem Int Ed Engl. 2019 Feb 18;58(8):2305-2309
pubmed: 30664319
J Am Chem Soc. 2016 May 18;138(19):6095-8
pubmed: 27140661
Chembiochem. 2011 Jun 14;12(9):1401-10
pubmed: 21656887
J Antibiot (Tokyo). 2007 Jun;60(6):391-4
pubmed: 17617698
Nat Methods. 2022 Jun;19(6):679-682
pubmed: 35637307
Nat Prod Rep. 2014 Nov;31(11):1554-84
pubmed: 24965099
Org Lett. 2018 Aug 17;20(16):4854-4857
pubmed: 30070849
Philos Trans R Soc Lond B Biol Sci. 2013 Jan 06;368(1612):20120434
pubmed: 23297356
J Biol Chem. 2010 May 28;285(22):16844-53
pubmed: 20375018
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
Angew Chem Int Ed Engl. 2023 Jan 16;62(3):e202213053
pubmed: 36314667
Future Med Chem. 2010 Sep;2(9):1451-68
pubmed: 21103389
Bioinformatics. 2020 Dec 22;36(20):5104-5106
pubmed: 32683443
Biochemistry. 2004 Nov 23;43(46):14712-21
pubmed: 15544342

Auteurs

Andrew J Devine (AJ)

School of Chemistry, University of Bristol, BS81TS, Bristol, UK.

Alice E Parnell (AE)

School of Biochemistry, University of Bristol, BS81TD, Bristol, UK.

Catherine R Back (CR)

School of Biochemistry, University of Bristol, BS81TD, Bristol, UK.

Nicholas R Lees (NR)

School of Chemistry, University of Bristol, BS81TS, Bristol, UK.

Samuel T Johns (ST)

School of Biochemistry, University of Bristol, BS81TD, Bristol, UK.

Ainul Z Zulkepli (AZ)

School of Biochemistry, University of Bristol, BS81TD, Bristol, UK.

Rob Barringer (R)

School of Biochemistry, University of Bristol, BS81TD, Bristol, UK.

Katja Zorn (K)

BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.

James E M Stach (JEM)

School of Natural and Environmental Sciences, Newcastle University, NE17RU, Newcastle-upon-Tyne, UK.

Matthew P Crump (MP)

School of Chemistry, University of Bristol, BS81TS, Bristol, UK.

Martin A Hayes (MA)

BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden.

Marc W van der Kamp (MW)

School of Biochemistry, University of Bristol, BS81TD, Bristol, UK.

Paul R Race (PR)

School of Biochemistry, University of Bristol, BS81TD, Bristol, UK.

Christine L Willis (CL)

School of Chemistry, University of Bristol, BS81TS, Bristol, UK.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Aspergillus Hydrogen-Ion Concentration Coculture Techniques Secondary Metabolism Streptomyces rimosus
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Saccharomyces cerevisiae Aldehydes Biotransformation Flavoring Agents Lipoxygenase

Classifications MeSH